Protective effect of Guanxinning on antipsychotic-induced cardiac impairment in long-term hospitalized psychiatric patients

Table 2 Baseline characteristics of the study participants, n (%)

Characteristics	Guanxinning intervention group (n = 60)	Control group (n = 60)	P values
Age (years)	42.5 ± 10.3	43.2 ± 9.8	0.703
Gender (male/female)	32/28	34/26	0.715
Duration of illness (years), mean ± SD	15.3 ± 7.2	14.8 ± 6.9	0.689
BMI (kg/m²), mean ± SD	26.4 ± 3.8	25.9 ± 4.1	0.481
Smoking	22 (36.7)	25 (41.7)	0.572
Total PANSS score, mean ± SD	52.6 ± 5.4	53.1 ± 5.2	0.602
Type of antipsychotic medication			0.934
Olanzapine	18 (30.0)	17 (28.3)
Risperidone	15 (25.0)	16 (26.7)
Aripiprazole	14 (23.3)	15 (25.0)
Other	13 (21.7)	12 (20.0)
Combined medications
Cardiovascular medications	8 (13.3)	7 (11.7)	0.785
Hypoglycemic drugs	6 (10.0)	5 (8.3)	0.752
Antidepressants	10 (16.7)	9 (15.0)	0.803

BMI: Body mass index; PANSS: Positive and negative syndrome score.